Labcorp Holdings Inc. provides comprehensive laboratory services that help doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. The Company provides insights and accelerates to improve health and improve lives through its unparalleled diagnostics and drug development capabilities. The Company operates through two segments: Diagnostics Laboratories (Dx) and Biopharma Laboratory Services (BLS). The Diagnostics Laboratories segment includes routine testing and specialty/esoteric testing. Dx operates through a network of patient service centers, branches, rapid response laboratories, primary laboratories, and specialty laboratories. The Biopharma Laboratory Services segment consists of early development research laboratories and central laboratory services. The Company is focused on four primary specialty testing areas, such as oncology, women's health, autoimmune disease, and neurology.
์ข
๋ชฉ ์ฝ๋ LH
ํ์ฌ ์ด๋ฆLabcorp Holdings Inc
์์ฅ์ผApr 24, 1991
CEOSchechter (Adam H)
์ง์ ์70000
์ ํOrdinary Share
ํ๊ณ ์ฐ๋ ์ข
๋ฃApr 24
์ฃผ์358 S Main St
๋์BURLINGTON
์ฆ๊ถ ๊ฑฐ๋์NASDAQ OMX NASDAQ Basic NYSE
๊ตญ๊ฐUnited States of America
์ฐํธ ๋ฒํธ27215
์ ํ13362291127
์น์ฌ์ดํธhttps://www.labcorp.com/
์ข
๋ชฉ ์ฝ๋ LH
์์ฅ์ผApr 24, 1991
CEOSchechter (Adam H)